Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OPTH · against 11 other Healthcare companies of similar size
Ranked #6 of 12 · scores higher than 45% of peers
Bars: peers in each 10-point band of the valuation score5 peers with a valuation score of 30–39, including OPTH · Click a bar to see the companies
Mainly because of its EBITDA yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | OPTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 10 reported | Not reported | -179.8% | — | — | 30% |
| EBITDA yieldHigher is better · 12 reported | -45.4% | -15.1% | 27% | 50% | |
| Free cash flow yieldHigher is better · 8 reported | -30.9% | -118.6% | 86% | 20% | |
| Book yieldHigher is better · 12 reported | Not reported | 104.7% | — | — | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.3B KRW (≈$10M) | 71 | 53 | |
| 2 | 3.5B JPY (≈$24M) | 65 | 48 | |
| 3 | 23M USD | 33 | ||
| 3 | 22M USD | 33 | 47 | |
| 3 | 17M USD | 33 | 10 | |
| 6 | 21.3B KRW (≈$15M) | 30 | 28 | |
| 6 | 12M USD | 30 | 38 | |
| 8 | 17M USD | 8 | 16 | |
| 8 | 17M USD | 8 | 18 | |
| 8 | 9M USD | 8 | 45 | |
| 11 | 18M AUD (≈$12M) | 0 | 7 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score